Acer therapeutics to participate in h.c. wainwright global investment conference

Newton, mass., may 05, 2022 (globe newswire) -- acer therapeutics inc. (nasdaq: acer), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, today announced that acer's management team will virtually present at, and participate in, the h.c. wainwright global investment conference may 24-26, 2022.
ACER Ratings Summary
ACER Quant Ranking